Emamectin Benzoate

Research use only, not for human use.

Emamectin Benzoate, by binding gamma-aminobutyric acid (GABA) receptor and glutamate-gated chloride channels disrupting nerve signals within arthropods, acts as a chloride channel activator.

Emamectin Benzoate, by binding gamma-aminobutyric acid (GABA) receptor and glutamate-gated chloride channels disrupting nerve signals within arthropods, acts as a chloride channel activator.

Cell Viability AssayCell Line:human normal bronchial epithelial cell line 16HBE Concentration:2.5, 5, 7.5,10,15, 20, 40 μM Incubation Time:12 and 24 hoursResult:Decreased cell viability in a time- and dose-dependent manner wirh IC50s of 11.88 μM and 9.67 μM in 12 and 24 hours, respectively.Apoptosis AnalysisCell Line:human normal bronchial epithelial cell line 16HBE Concentration:2.5, 5, 10, 20 μM Incubation Time:24 hours Result:Induced apoptosis and caused chromatin shrinkage and nuclear fragmentation.Western Blot Analysis Cell Line:human normal bronchial epithelial cell line 16HBE Concentration:2.5, 5, 10, 20 μM Incubation Time:12 hours Result:Increased the amounts of cytochrome-c, caspase-3, cas-pase-9, cleaved-PARP, Bax/Bcl-2.

Animal Model:10 weeks old Swiss albino male mice (25-30 g)Dosage:25, 50, 100 mg/kg Administration:Oral; daily; for 14 days Result:Caused a marked induction of oxidative damage in liver tissue as demonstrated by an increased level of TBARS and reduced GSH level.

MK-244

Membrane Transporter/Ion Channel

Other Targets

GABA Receptor

——

——

155569-91-8

1880.33

C104H154N2O28

>98% (HPLC)

DMSO:31 mg/mL (16.49 mM)

CC[C@H](C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)NC)OC)OC)\C)C.C1=CC=C(C=C1)C(=O)O

——

(-20℃)

With Ice Pack

≥ 2 years